Skip to main content
Understanding so you can act early

Uveal melanoma (eye melanoma)

No organized cancer screening

500 to 600 new cases per year in France 1

What is it?

Uveal melanoma is a cancer of melanocytes, the pigment-producing cells, that develops in the eye: it is the main eye cancer in adults 1.

How it develops

It can develop in a previously healthy eye or from a mole in the eye (choroidal nevus). The tumor grows inside the eye. Because the eye has no lymphatic vessels, it spreads through the blood: when it spreads, the liver is the first site in more than 9 in 10 cases 1.

How long does it take to develop?

The tumor often develops for a long time before the first signs appear. Metastases may sometimes appear more than 10 years after the eye tumor is found 1.

Risk factors

  • Age: most often between 50 and 70 1
  • Light-colored eyes (blue, green, gray): 2 to 3 times the risk compared with brown eyes 1
  • Fair skin 2
  • Many moles, including in the eye (choroidal or iris nevi, ocular melanocytosis) 2
  • Atypical mole syndrome 2
  • BAP1 predisposition syndrome, rare and hereditary 2
  • Welding, through intense UV exposure 2

What helps protect you: A role for sunlight has not been established for this cancer 12.

Signs that should prompt a visit to your doctor

  • Often no signs
  • Found during an examination of the back of the eye by an ophthalmologist
  • Blurred vision
  • A spot in the field of vision
  • Flashes of light
  • Loss of side vision
  • It mainly spreads to the liver

These signs do not necessarily mean cancer. Unsure? Talk to your ophthalmologist.

³

Blurred or reduced vision, a spot in the field of vision, flashes of light, loss of side vision, a dark spot on the iris or a change in the eye’s appearance; pain is rare. In about 1 in 3 cases, it is found without any signs during a routine eye examination by an ophthalmologist (examination of the back of the eye) 14.

Detected early or at a later stage

It is detected by examining the back of the eye after dilating the pupil, and confirmed by an eye ultrasound. Metastases develop in 30 to 50 % of people during follow-up 1.

5-year survival by stage

FOUND AT A LATER STAGEFOUND EARLY
Localizedstages I–III
88 %

5-year relative survival in the United States 5. In France, 5-year net survival: 74 % 6.

Approximate correspondence with the clinical classification (TNM/FIGO); this varies depending on the tumour's characteristics.

Screening in France

No, there is no organized cancer screening. Regular examinations by an ophthalmologist can identify and monitor a mole in the eye.

Monitoring for people at risk

After detection, liver surveillance with ultrasound every 6 months, and MRI for people at higher risk 1.

A female doctor talking with a female patient in a bright consulting room
A concern or an unexplained symptom? Talk to your doctor.
Prevonco

Prevonco is currently available in France only.

An aid to the early detection of 16 cancers

No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.

Pre-register for free →

Frequently asked questions

Do I need a prescription?

No. With Prevonco, you do not need a prescription: after ordering online, a unique code gives you access to the test at one of our partner laboratories. In France, some laboratory tests can be carried out at your request, without a prescription.

No prescription, but still a doctor: they remain central to the process. Your result is sent to the doctor you selected from our panel, who will explain it during a 30-minute video consultation, included whatever the result.

Are you receiving care for cancer? Speak directly to your oncologist: they can prescribe this test without going through Prevonco.

For any questions about your situation, or if you have symptoms, your doctor remains your first point of contact.

What if my level is high?

A high level tends to be a strong signal. It is not a conclusion: its cause needs to be investigated with a doctor.⁷

Your result is sent to the doctor you selected from our panel. They will explain it during the 30-minute video consultation included in the price. Further investigations prescribed by a doctor can help identify the cause.⁷

What if the level is intermediate? It may not be related to cancer (smoking, an inflammatory condition, etc.). Other blood tests may be suggested; if they are normal, a repeat check is planned at 12 months. You will never be left to face your result alone.⁷

What if my level is low?

That is reassuring, but no test is perfect: a low level does not rule everything out.⁷

If you have no symptoms, no specific follow-up is recommended after a low result. The risk of a false negative varies by cancer type.⁷

Your doctor, who is trained in functional medicine and specialises in prevention, will help you explore any concerns or symptoms during the 30-minute video consultation.⁷

Keep up with your usual screening: respond to invitations for organised screening programmes, and see your doctor if a symptom appears.⁷

How long will it take to get my results?

The laboratory analysis takes 30 days. Your full results are presented by a doctor trained in functional medicine during a 30-minute consultation included in your package.

You choose the date and time slot that suit you for this appointment.

All frequently asked questions →
Prevonco

Prevonco is currently available in France only.

An aid to the early detection of 16 cancers

No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.

Pre-register for free →

General information for educational purposes: it does not replace your doctor's advice. An aid to early detection: it does not replace organised screening, imaging tests or your doctor's advice.